Form 4: Organon Director Cynthia Patton Boosts Stake Through Phantom Stock Acquisition

Organon & Co. Director Cynthia M. Patton acquired 23,904.382 phantom stock units on June 13, 2025, increasing her total beneficial ownership to 62,702.653 units.

Summary

• Cynthia M. Patton, a Director at Organon & Co. (OGN), reported a change in her beneficial ownership via an SEC Form 4 filing.
• On June 13, 2025, Ms. Patton acquired 23,904.382 phantom stock units.
• These phantom stock units were acquired at a price of $10.04 per unit.
• Each phantom stock unit is an economic equivalent of one share of Organon & Co. common stock.
• The units were granted under the Organon Non-Employee Director Savings Plan and are payable in cash upon settlement after her termination of service as a director.
• Following this transaction, Ms. Patton's total beneficial ownership of phantom stock units increased to 62,702.653 units.
• This total includes units acquired through dividend reinvestment transactions on June 13, 2024, September 12, 2024, December 12, 2024, March 13, 2025, and June 12, 2025.

Sentiment

Score: 7

Explanation: The document reports a routine insider transaction related to director compensation. The acquisition of additional phantom stock units by a director, even if not direct equity, generally signals continued alignment of interests and confidence in the company, leading to a slightly positive sentiment.

Positives

• The acquisition of additional phantom stock units by a director can signal continued confidence in the company's future performance and strategic direction.
• The transaction is part of a structured compensation plan (Organon Non-Employee Director Savings Plan), indicating a systematic alignment of director incentives with shareholder interests.

Negatives

• The phantom stock units are payable in cash upon settlement rather than actual shares, meaning they do not directly increase the director's voting equity in the company.

Future Outlook

The document, an SEC Form 4, does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing details a routine insider transaction related to director compensation within the pharmaceutical/healthcare industry. Such transactions are common and reflect standard practices for aligning executive and director interests with company performance.

Corporate Governance

Related Party Transactions

• The acquisition of phantom stock units by Cynthia M. Patton, a Director of Organon & Co., constitutes a related party transaction as it involves compensation provided by the company to a member of its board of directors under a pre-established plan.

Stakeholder Impact

• Shareholders: The increased beneficial ownership by a director, even through phantom stock, can be viewed as a positive signal of management's confidence in the company's future, potentially reinforcing investor sentiment.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The phantom stock units are payable in cash upon settlement after the reporting person's termination of service as a director, as per the terms of the Organon Non-Employee Director Savings Plan.

Key Dates

Recommendation

Keywords

Organon & Co., OGN, SEC Form 4, Insider Transaction, Beneficial Ownership, Phantom Stock, Director Compensation, Equity Compensation, Dividend Reinvestment